Heart failure & cardiomyopathiesResearch article

Optimising Transitions of Care and Long-Term Management in Heart Failure: A Scoping Review of Strategies and Models

ESC Heart FailPublished

  • Scoping review
  • PRISMA extension for scoping reviews (PRISMA-ScR) checklist
  • two systematic searches
  • two independent reviewers

Authors' conclusion

Despite heterogeneity across healthcare systems and variability in programme designs, the evidence supports coordinated and patient-centred strategies for HF care transitions and long-term follow-up. These approaches reduce mortality and rehospitalisation, enhance patient engagement and quality of life, and provide a sustainable framework for healthcare systems.

Study context

Population
Patients with heart failure (HF); records published from January 2015 to June 2024 on transitional care and long-term follow-upstudies considered eligible, n=73 deemed most relevant synthesised qualitatively
Participants
118 patients

Main finding

As reported in the abstract

30-day rehospitalisation with structured discharge planning with close follow-up · 30-day

Reduced 30-day rehospitalisation

20%-50%

Early follow-up

50%

Nursing coordination

30%

Pharmaceutical intervention

20%

Further findings

Hospitalisation and mortality with one nurse-led programme including calls and visits · six weeks (hospitalisation); nine months (mortality)

Hospitalisation at six weeks decreased from 16.3% to 8.1%
P = 0.048
Mortality at nine months decreased from 13.8% to 4.1%
P = 0.03

Death or rehospitalisation for cardiovascular events with risk-stratification-based management

Reduced by 12%
HR [hazard ratio]: 0.88; p=0.04

Rehospitalisation or death with an intensive programme with education, exercise, and close monitoring · 30 days and 90 days

Lowered at 30 days
38%
Lowered at 90 days
39%

Other strategies

Multidisciplinary HF units, day care hospitals, and home hospitalisation improved adherence and outcomes
Telemedicine and remote monitoring enabled early detection of decompensation
Pharmacist- and nurse-led interventions enhanced medication safety and adherence
Psychosocial and caregiver support improved self-management and quality of life

Characteristics of synthesised studies

Published after 2020
53.4%
Europe and North America
75.3%
Intervention studies
32.9%
Randomised controlled trials (of intervention studies)
45.8%

Original publication

Optimising Transitions of Care and Long-Term Management in Heart Failure: A Scoping Review of Strategies and Models. ESC Heart Fail. Published 20 January 2026. doi:10.1093/eschf/xvag035

Summarised from the published abstract; every number is checked against it